Prospective evaluation of fever of unknown origin in patients infected with the human immunodeficiency virus. Grupo Andaluz para el Estudio de las Enfermedades Infecciosas. 1996

F Lozano, and J Torre-Cisneros, and A Bascuñana, and J Polo, and P Viciana, and M A García-Ordóñez, and J Hernández-Quero, and M Márquez, and A Vergara, and F Díez, and E Pujol, and M Torres-Tortosa, and J Pasquau, and J J Hernández-Burruezo, and I Suárez
Infectious Diseases Section, Hospital Universitario de Valme, Seville, Spain.

The aim of this study was to determine the frequency and aetiology of fever of unknown origin (FUO) in patients infected with the human immunodeficiency virus (HIV), to assess the value of the tests used in its diagnosis, and to evaluate possible models of diagnosis for the causes found most frequently. One hundred twenty-eight (3.5%) of 3603 hospitalised HIV-positive patients evaluated from October 1992 to December 1993 had FUO, defined by established criteria. Eighty-six percent of patients with FUO had previously progressed to AIDS. The median CD4+ cell count was 46/mm3. A definite diagnosis was made in 96 (75%) of the 128 patients and a possible diagnosis in 24 (18.7%). whilst no diagnosis was made in eight cases (6.2%). Tuberculosis (48.3%), visceral leishmaniasis (16%), and infection by Mycobacterium avium complex (6.9%) were the diseases found most frequently. The most useful diagnostic tests were liver biopsy (68.9%) and bone marrow aspirate/biopsy (39.7%). It is not possible to predict clinically the cases of FUO due to tuberculosis, whilst thrombocytopaenia < 100,000 cells/mm3 alone is useful for differentiating the cases of visceral leishmaniasis, with a negative predictive value of 95.2%.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D005335 Fever of Unknown Origin Fever in which the etiology cannot be ascertained. Unknown Origin Fever,Unknown Origin Fevers
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

F Lozano, and J Torre-Cisneros, and A Bascuñana, and J Polo, and P Viciana, and M A García-Ordóñez, and J Hernández-Quero, and M Márquez, and A Vergara, and F Díez, and E Pujol, and M Torres-Tortosa, and J Pasquau, and J J Hernández-Burruezo, and I Suárez
March 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
F Lozano, and J Torre-Cisneros, and A Bascuñana, and J Polo, and P Viciana, and M A García-Ordóñez, and J Hernández-Quero, and M Márquez, and A Vergara, and F Díez, and E Pujol, and M Torres-Tortosa, and J Pasquau, and J J Hernández-Burruezo, and I Suárez
December 2000, American journal of respiratory and critical care medicine,
F Lozano, and J Torre-Cisneros, and A Bascuñana, and J Polo, and P Viciana, and M A García-Ordóñez, and J Hernández-Quero, and M Márquez, and A Vergara, and F Díez, and E Pujol, and M Torres-Tortosa, and J Pasquau, and J J Hernández-Burruezo, and I Suárez
May 1992, Enfermedades infecciosas y microbiologia clinica,
F Lozano, and J Torre-Cisneros, and A Bascuñana, and J Polo, and P Viciana, and M A García-Ordóñez, and J Hernández-Quero, and M Márquez, and A Vergara, and F Díez, and E Pujol, and M Torres-Tortosa, and J Pasquau, and J J Hernández-Burruezo, and I Suárez
September 1992, Revista clinica espanola,
F Lozano, and J Torre-Cisneros, and A Bascuñana, and J Polo, and P Viciana, and M A García-Ordóñez, and J Hernández-Quero, and M Márquez, and A Vergara, and F Díez, and E Pujol, and M Torres-Tortosa, and J Pasquau, and J J Hernández-Burruezo, and I Suárez
February 1998, Journal of clinical microbiology,
F Lozano, and J Torre-Cisneros, and A Bascuñana, and J Polo, and P Viciana, and M A García-Ordóñez, and J Hernández-Quero, and M Márquez, and A Vergara, and F Díez, and E Pujol, and M Torres-Tortosa, and J Pasquau, and J J Hernández-Burruezo, and I Suárez
January 2018, Gaceta medica de Mexico,
F Lozano, and J Torre-Cisneros, and A Bascuñana, and J Polo, and P Viciana, and M A García-Ordóñez, and J Hernández-Quero, and M Márquez, and A Vergara, and F Díez, and E Pujol, and M Torres-Tortosa, and J Pasquau, and J J Hernández-Burruezo, and I Suárez
July 1994, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
F Lozano, and J Torre-Cisneros, and A Bascuñana, and J Polo, and P Viciana, and M A García-Ordóñez, and J Hernández-Quero, and M Márquez, and A Vergara, and F Díez, and E Pujol, and M Torres-Tortosa, and J Pasquau, and J J Hernández-Burruezo, and I Suárez
January 1996, Revista clinica espanola,
F Lozano, and J Torre-Cisneros, and A Bascuñana, and J Polo, and P Viciana, and M A García-Ordóñez, and J Hernández-Quero, and M Márquez, and A Vergara, and F Díez, and E Pujol, and M Torres-Tortosa, and J Pasquau, and J J Hernández-Burruezo, and I Suárez
September 1995, Antimicrobial agents and chemotherapy,
F Lozano, and J Torre-Cisneros, and A Bascuñana, and J Polo, and P Viciana, and M A García-Ordóñez, and J Hernández-Quero, and M Márquez, and A Vergara, and F Díez, and E Pujol, and M Torres-Tortosa, and J Pasquau, and J J Hernández-Burruezo, and I Suárez
January 2000, Medicina,
Copied contents to your clipboard!